Literature DB >> 8689915

Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.

B I Hirschowitz1.   

Abstract

The objective of this study was to determine whether gastric secretion of acid and pepsin is different in the subset of esophagitis patients who also have Barrett's esophagus. Basal and stimulated gastric secretions were studied for 1 hr in the unstimulated state and 1 hr after pentagastrin 6 microg/kg subcutaneous injection. Because Barrett's patients are predominantly male, the 30 patients were matched with patients who had esophagitis, but not Barrett's, for sex (26 men, 4 women) and age as well as for background gastrointestinal disease (duodenal ulcer in 10, no ulcer disease in 17 and Zollinger-Ellison hypersecretors in 3). Patients with Barrett's weighed more than controls (P < 0.05). Acid and pepsin output in the basal and stimulated state were no different in Barrett's and their appropriately matched controls. Overnight fasting residue--volume, pH, acid and pepsin concentrations, and bile content--were also alike. The severity of esophagitis or prevalence of esophageal ulcer or stricture was not different between those with and without Barrett's and in neither was the grade of esophagitis related to acid or pepsin output. It is concluded that Barrett's esophagus patients do not have gastric secretions different from appropriately matched controls with esophagitis alone. When present, esophagitis due to reflux in Barrett's epithelium should be treated on its merits by appropriate reduction of acid exposure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689915     DOI: 10.1007/bf02088563

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Barrett's esophagus: age, prevalence, and extent of columnar epithelium.

Authors:  A J Cameron; C T Lomboy
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

2.  Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion.

Authors:  S A McClave; H W Boyce; M R Gottfried
Journal:  Gastrointest Endosc       Date:  1987-12       Impact factor: 9.427

Review 3.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Regression of Barrett's esophagus by laser ablation in an anacid environment.

Authors:  R E Sampliner; L J Hixson; M B Fennerty; H S Garewal
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

5.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

Authors:  D J Hetzel; J Dent; W D Reed; F M Narielvala; M Mackinnon; J H McCarthy; B Mitchell; B R Beveridge; B H Laurence; G G Gibson
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

6.  Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma.

Authors:  D A Katzka; J C Reynolds; S H Saul; A Plotkin; C A Lang; A Ouyang; S Jimenez; S Cohen
Journal:  Am J Med       Date:  1987-01       Impact factor: 4.965

7.  Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy.

Authors:  S Gore; C J Healey; R Sutton; I A Eyre-Brook; M W Gear; N A Shepherd; S P Wilkinson
Journal:  Aliment Pharmacol Ther       Date:  1993-12       Impact factor: 8.171

8.  Composition of gastro-oesophageal refluxate.

Authors:  D C Gotley; A P Morgan; D Ball; R W Owen; M J Cooper
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

9.  Esophageal function and occurrence of Barrett's esophagus in Zollinger-Ellison syndrome.

Authors:  D B Strader; S B Benjamin; M Orbuch; T A Lubensky; F Gibril; C Weber; V A Fishbeyn; R T Jensen; D C Metz
Journal:  Digestion       Date:  1995       Impact factor: 3.216

10.  Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus.

Authors:  S E Attwood; T R DeMeester; C G Bremner; A P Barlow; R A Hinder
Journal:  Surgery       Date:  1989-10       Impact factor: 3.982

View more
  13 in total

1.  The pathogenesis of Barrett's esophagus: a process in continuum or discontinuum.

Authors:  R C Fitzgerald; M J Farthing
Journal:  Curr Gastroenterol Rep       Date:  2000-12

2.  Prostaglandin E2 is the major arachidonic acid metabolite secreted by esophageal mucosal cells in rabbits.

Authors:  P Jiménez; A Lanas; E Piazuelo; G Bioque; F Esteva
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

3.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Acid reflux is a poor predictor for severity of erosive reflux esophagitis.

Authors:  Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Stephen J Sontag
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

5.  Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.

Authors:  Malcolm Robinson; Sheila Rodriguez-Stanley; Arthur A Ciociola; Jonathan Filinto; Sattar Zubaidi; Philip B Miner; Jerry D Gardner
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

6.  Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus.

Authors:  Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Stephen J Sontag
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

7.  Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

Review 8.  Barrett's oesophagus: optimal strategies for prevention and treatment.

Authors:  Ronnie Fass; Richard E Sampliner
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Pepsin and the esophagus.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun

Review 10.  pH, healing rate, and symptom relief in patients with GERD.

Authors:  J Q Huang; R H Hunt
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.